{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T01:29:05Z","timestamp":1760059745788,"version":"build-2065373602"},"reference-count":30,"publisher":"MDPI AG","issue":"7","license":[{"start":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T00:00:00Z","timestamp":1751587200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diseases"],"abstract":"<jats:p>Background: Cholangiocarcinoma, malignancies arising from the intrahepatic and extrahepatic bile ducts, has increased in incidence in the United States over the past few decades. The reported incidence of cholangiocarcinomas is high, particularly in specific racial groups such as Asian and Pacific Islander patients. Race also significantly impacts disparities in healthcare utilization and clinical outcomes. Our study focused on the impact of race on admission, clinical outcomes, and disposition of cholangiocarcinoma. Methods: We performed a retrospective analysis of cholangiocarcinoma-related hospital admissions, using the National Inpatient Sample for the year 2022. Patients were stratified according to race into the following groups: White, African American, Hispanic, Asian or Pacific Islander, Native American, and Other. The data analysis was performed using STATA\/BE version 18.5. Univariable and multivariable logistic regression models were applied to evaluate the relationship between race and clinical and healthcare utilization outcomes. Results: In 2022, 7479 hospitalizations were recorded for cholangiocarcinoma in the United States. Among these, 65.99% were White, 13.27% Hispanic, and 10.13% African American. There was a statistically significant difference in gender distribution across racial groups (p &lt; 0.001), with males comprising the majority in all groups. Males outnumbered females in all racial groups except among the Hispanic group. Significant racial disparities in mortality were observed, with White patients showing a mortality rate of 6.69%, compared to higher rates among African American (9.76%), Native American (8.51%), and Asian or Pacific Islander (8.09%) patients, while Hispanic (5.04%) and Other (5.88%) groups had lower rates (p &lt; 0.001). Conclusions: The study underscores the racial disparities among cholangiocarcinoma hospitalizations, with African American, Native American, and Asian patients facing disproportionately higher mortality and poorer in-hospital outcomes compared to White patients. This analysis highlights the healthcare strategies and policy reforms to promote equitable treatment by mitigating these disparities and to improve cholangiocarcinoma outcomes.<\/jats:p>","DOI":"10.3390\/diseases13070211","type":"journal-article","created":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T05:54:52Z","timestamp":1751608492000},"page":"211","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of Race on Admission, Clinical Outcomes, and Disposition in Cholangiocarcinoma: Insights from the National Inpatient Database"],"prefix":"10.3390","volume":"13","author":[{"given":"Tijin A.","family":"Mathew","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Southeast Health Dothan, Dothan, AL 36301, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa M.","family":"Varghese","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wellstar Spalding, Griffin, GA 30224, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nithya","family":"Krishnakumaran","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Southeast Health Dothan, Dothan, AL 36301, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George M.","family":"Varghese","sequence":"additional","affiliation":[{"name":"Department of Cardiovascular Medicine, Stanford University, Stanford, CA 94305, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khwaja S.","family":"Haq","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Wellstar Spalding, Griffin, GA 30224, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akshita","family":"Khosla","sequence":"additional","affiliation":[{"name":"Department of Hematology and Oncology, Louisiana State University, New Orleans, LA 70112, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rojymon","family":"Jacob","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, The University of Mississippi Medical Center, Jackson, MS 39216, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gina","family":"Vaccaro","sequence":"additional","affiliation":[{"name":"Department of Hematology Oncology, Tennessee Oncology, Nashville, TN 37203, USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2025,7,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/hep.24351","article-title":"Risk factors for cholangiocarcinoma","volume":"54","author":"Tyson","year":"2011","journal-title":"Hepatology"},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Lauterio, A., De Carlis, R., Centonze, L., Buscemi, V., Incarbone, N., Vella, I., and De Carlis, L. (2021). Current surgical management of peri-hilar and intra-hepatic cholangiocarcinoma. Cancers, 13.","DOI":"10.3390\/cancers13153657"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1055\/s-2004-828889","article-title":"The epidemiology of cholangiocarcinoma","volume":"24","author":"Shaib","year":"2004","journal-title":"Semin. Liver Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1158\/1055-9965.EPI-21-0265","article-title":"Incidence and mortality of cancers of the biliary tract, gallbladder, and liver by sex, age, race\/ethnicity, and stage at diagnosis: United States, 2013 to 2017","volume":"30","author":"Ellington","year":"2021","journal-title":"Cancer Epidemiol. Biomarkers Prev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.14309\/ajg.0000000000001151","article-title":"Trends in the mortality of biliary tract cancers based on their anatomical site in the United States from 2009 to 2018","volume":"116","author":"Kim","year":"2021","journal-title":"Am. J. Gastroenterol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1093\/oncolo\/oyac150","article-title":"Temporal changes in cholangiocarcinoma incidence and mortality in the United States from 2001 to 2017","volume":"27","author":"Javle","year":"2022","journal-title":"Oncologist"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.jhep.2019.03.013","article-title":"Global trends in mortality from intrahepatic and extrahepatic cholangiocarcinoma","volume":"71","author":"Bertuccio","year":"2019","journal-title":"J. Hepatol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1111\/hepr.12605","article-title":"Sex-specific and race\/ethnicity-specific disparities in cholangiocarcinoma incidence and prevalence in the USA: An updated analysis of the 2000\u20132011 Surveillance, Epidemiology and End Results registry","volume":"46","author":"Mosadeghi","year":"2016","journal-title":"Hepatol. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1002\/jso.25632","article-title":"Race, ethnicity, and socioeconomic factors in cholangiocarcinoma: What is driving disparities in receipt of treatment?","volume":"120","author":"Lee","year":"2019","journal-title":"J. Surg. Oncol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1097\/MEG.0000000000001572","article-title":"Increased odds of cholangiocarcinoma in Hispanics: Results of a nationwide analysis","volume":"32","author":"Ruiz","year":"2020","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5114\/pg.2015.49004","article-title":"Diabetes mellitus and the risk of cholangiocarcinoma: An updated meta-analysis","volume":"10","author":"Li","year":"2015","journal-title":"Gastroenterol. Rev."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"6831","DOI":"10.1007\/s13277-014-1939-4","article-title":"Obesity and the risk of cholangiocarcinoma: A meta-analysis","volume":"35","author":"Li","year":"2014","journal-title":"Tumor Biol."},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Petrick, J.L., Yang, B., Altekruse, S.F., Van Dyke, A.L., Koshiol, J., Graubard, B.I., and McGlynn, K.A. (2017). Risk factors for intrahepatic and extrahepatic cholangiocarcinoma in the United States: A population-based study in SEER-Medicare. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0186643"},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1056\/NEJM199910283411807","article-title":"Biliary tract cancers","volume":"341","author":"Gores","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"ref_15","unstructured":"Healthcare Cost and Utilization Project (HCUP) (2025, May 23). Introduction to the HCUP National Inpatient Sample (NIS) 2020, Available online: https:\/\/www.hcup-us.ahrq.gov\/db\/nation\/nis\/NISIntroduction2020.pdf."},{"key":"ref_16","unstructured":"Agency for Healthcare Research and Quality (2025, May 23). HCUP Clinical Classifications Software Refined (CCSR) for ICD-10-CM Diagnoses, v2021.2, Available online: https:\/\/www.hcup-us.ahrq.gov\/toolssoftware\/ccsr\/dxccsr.jsp."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1097\/MEG.0000000000002313","article-title":"Controversial risk factors for cholangiocarcinoma","volume":"34","author":"Baidoun","year":"2022","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"e2400537","DOI":"10.1200\/GO-24-00537","article-title":"Disparities in cholangiocarcinoma research and trials: Challenges and opportunities in the United States","volume":"11","author":"Abioye","year":"2025","journal-title":"JCO Glob. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","unstructured":"Yao, K.J., Jabbour, S., Parekh, N., Lin, Y., and Moss, R.A. (2016). Increasing mortality in the United States from cholangiocarcinoma: An analysis of the National Center for Health Statistics Database. BMC Gastroenterol., 16.","DOI":"10.1186\/s12876-016-0527-z"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1200\/JCO.2025.43.4_suppl.527","article-title":"Ethnic and socioeconomic disparities in cancer-free and all-cause survival in cholangiocarcinoma patients under 60: A population-based study","volume":"43","author":"Dharia","year":"2025","journal-title":"J. Clin. Oncol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.5604\/01.3001.0012.0929","article-title":"Racial, ethnic, and age disparities in incidence and survival of intrahepatic cholangiocarcinoma in the United States; 1995\u20132014","volume":"17","author":"Antwi","year":"2018","journal-title":"Ann. Hepatol."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"6631","DOI":"10.1200\/JCO.2023.41.16_suppl.6631","article-title":"Racial disparities in hospitalization outcomes among patients with cholangiocarcinoma","volume":"41","author":"Jackson","year":"2023","journal-title":"J. Clin. Oncol."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.1245\/s10434-023-13122-1","article-title":"Racial segregation among patients with cholangiocarcinoma-impact on diagnosis, treatment, and outcomes","volume":"30","author":"Munir","year":"2023","journal-title":"Ann. Surg. Oncol."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Liu, Y., Xu, X., and Ye, X. (2024). The benefits of an offline to online cognitive behavioral stress management regarding anxiety, depression, spiritual well-being, and quality of life in postoperative intrahepatic cholangiocarcinoma patients. Asia Pac. J. Clin. Oncol., Epub ahead of print.","DOI":"10.1111\/ajco.14093"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"856","DOI":"10.6004\/jnccn.2020.7534","article-title":"Outcomes of patients with cancer discharged to a skilled nursing facility after acute care hospitalization","volume":"18","author":"Singh","year":"2020","journal-title":"J. Natl. Compr. Cancer Netw."},{"key":"ref_26","first-page":"213","article-title":"Healthcare utilization and costs associated with cholangiocarcinoma","volume":"5","author":"Wadhwa","year":"2017","journal-title":"Gastroenterol. Rep."},{"key":"ref_27","unstructured":"HCUP Clinical Classifications Software Refined (CCSR) Chronic Condition Indicator for ICD-10-CM Diagnoses, v2021.21 (2025, May 23). Agency for Healthcare Research and Quality, Available online: https:\/\/hcup-us.ahrq.gov\/toolssoftware\/ccsr\/ccs_refined.jsp."},{"key":"ref_28","first-page":"1210","article-title":"Treatment tolerance and outcomes in older adults with cancer: A systematic review","volume":"101","author":"Kumar","year":"2009","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Mojtahedi, Z., Yoo, J.W., Callahan, K., Bhandari, N., Lou, D., Ghodsi, K., and Shen, J.J. (2021). Inpatient palliative care is less utilized in rare, fatal extrahepatic cholangiocarcinoma: A ten-year national perspective. Int. J. Environ. Res. Public Health, 18.","DOI":"10.3390\/ijerph181910004"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"339","DOI":"10.21037\/jgo.2018.12.07","article-title":"Trends in surgery and disparities in receipt of surgery for intrahepatic cholangiocarcinoma in the US: 2005\u20132014","volume":"10","author":"Ransome","year":"2019","journal-title":"J. Gastrointest. Oncol."}],"container-title":["Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2079-9721\/13\/7\/211\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,9]],"date-time":"2025-10-09T18:04:26Z","timestamp":1760033066000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2079-9721\/13\/7\/211"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,4]]},"references-count":30,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["diseases13070211"],"URL":"https:\/\/doi.org\/10.3390\/diseases13070211","relation":{},"ISSN":["2079-9721"],"issn-type":[{"type":"electronic","value":"2079-9721"}],"subject":[],"published":{"date-parts":[[2025,7,4]]}}}